cannabis cultivation in a dark room, black background potted marijuana plant, medical cannabis TORONTO (January 17, 2020) – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”) is pleased to announce that Executive Co-Chairman and CEO Dr. Raza Bokhari, along with the founders, members of …Read More »
Tag Archives: FSDPharma
Donal Carroll Appointed Chief Financial Officer, Dr. Sandra Lottes as Vice President and Head of Clinical Research at BioSciences Division, and Shahzad Shah as Chief Operating Officer at FV Pharma – TORONTO, Jan. 2, 2020 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced the appointments of three key …Read More »
TORONTO (December 16, 2019) – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares (the “Shares”) listed on the Nasdaq Capital Market (“Nasdaq”). FSD Pharma expects the Shares to commence trading …Read More »
TORONTO (December 13, 2019) – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, will present an overview of the Company at the Investor Summit conference at 2:35 p.m. ET on Tuesday, December 17, 2019 …Read More »
Canada, November 29, 2019 (CISION)- Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20 – – Raises $4.59 million in additional capital at $20.10 per share – TORONTO, Nov. 29, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today reported financial …Read More »
FSD PHARMA SECOND TRANCHE OF PRIVATE PLACEMENT CLOSES, TOTAL OF $4.59 MILLION RAISED AT $20.10 TO DATE, EXTENDS OFFERING
TORONTO, November 4, 2019 – (FSD Pharma Inc.) (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) (“FSD” or the “Company“) announces that it has closed a second tranche of its previously announced private placement (the “Private Placement“), and has now raised total gross proceeds of CAD $4,596,285 from investors, including members of senior management …Read More »
TORONTO, October 23, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) announces that an amended and restated management’s discussion and analysis for the year ended December 31, 2018 (the “Amended 2018 MD&A“) has been filed on SEDAR to better comply with National Instrument …Read More »
In early 2019, the leadership at FSD Pharma Inc. (CSE: HUGE, OTCQB: FSDDD, Forum) realized that the nascent cannabis industry in Canada is heading into a supply gut and a major shortfall in sales. The medical research and development Company terminated its joint venture agreement with Auxly Cannabis Group Inc. (TSX-V: XLY), which was a controversial move, but …Read More »
Canada, October 17, 2019 (INVESTMENT PITCH MEDIA) The temporary change is protocol for stocks that trade on US exchanges that undergo structural events, such as the recent share consolidation of one new share for each 201 old shares, announced by FSD Pharma on October 11th, in order to advance the company’s …Read More »
FSD Pharma announced that the Company’s Class B Shares are trading on the OTCQB under the ticker symbol FSDDD
TORONTO, Oct. 17, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) (“FSD” or the “Company”) today announced that the Company’s Class B Shares are trading on the OTCQB under the ticker symbol FSDDD for 20 business days, effective as of October 16, 2019. On November 13, 2019, the OTCQB symbol …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!